期刊文献+

肽YY_(3-36)、胰升糖素样肽-1_(7-36)联合及单独用药对健康人群食欲和血糖的影响

The Effects of Combined and Separate Application of YY_(3-36) and/or Glucagons-like Peptide-1_(7-36) on the Appetite and the Blood Glucose in Health Population
下载PDF
导出
摘要 目的探讨肽YY3鄄36穴PYY3鄄36雪、胰升糖素样肽鄄17鄄36(GLP鄄17鄄36)联合及单独用药对食欲和血糖的影响。方法健康志愿者行双盲对照,分别注射盐水(saline)、PYY3鄄36、GLP鄄17鄄36、PYY3鄄36+GLP鄄17鄄36,观察其能量摄入情况。留取血样测定肽YY(PYY)、胰升糖素样肽鄄1(GLP鄄1)、葡萄糖、胰岛素。结果同盐水组比较,PYY3鄄36+GLP鄄17鄄36组、PYY3鄄36组及GLP鄄17鄄36组摄取食物能量明显减少(对能量摄取与盐水组相比较,其百分比依次为PYY3鄄36+GLP鄄17鄄36(鄄28±2%),PYY3鄄36(鄄15±6%),GLP鄄17鄄36(鄄5±5%);在PYY3鄄36+GLP鄄17鄄36组、PYY3鄄36组PYY浓度增加,GLP鄄17鄄36组下降。PYY3鄄36+GLP鄄17鄄36组、GLP鄄17鄄36组GLP鄄1浓度增加,PYY3鄄36组无明显变化;在GLP鄄17鄄36组、PYY3鄄36+GLP鄄17鄄36组输入90min时胰岛素浓度增加,PYY3鄄36组无明显变化。GLP鄄17鄄36组、PYY3鄄36+GLP鄄17鄄36组输入90min时血糖浓度降低,PYY3鄄36组无明显变化。结论PYY3鄄36+GLP鄄17鄄36有明显抑制食欲作用熏其程度依次高于PYY3鄄36、GLP鄄17鄄36,且PYY3鄄36+GLP鄄17鄄36及GLP鄄17鄄36能降低血糖。 Objective To investigate the effects of peptide YY3-36 (PYY3-36) and glucagon-like peptide-1 (GLP-17-36) infusion in health people. Methods Ten volunteers were divided into four groups and injected respectively with saline, GLP-17-36 PYY3-36 or PYY3-36+ GLP-17-36. Energy expenditures were measured before and after a free buffet lunch. Blood samples were obtained for the content analysis of PYY, GLP-1, Glucose and Insulin. Results (1)Combined with the saline group, the daily food intake was decreased by 28±2% in PYY3-36+GLP-17-36 group, 15±6% in PYY3-36 and 5±5% in GLP-17-36; (2)There were significant increases in plasma PYY levels with PYY3-36 and PYY3-36 + GLP-17-36 infusions, and GLP-1 levels with GLP-17-36 and PYY3-36 +GLP-17-36 infusions; (3) Plasma insulin was increased and glucose was reduced by GLP-17-36 infusion at 90 minutes compared with saline but not changed with PYY3-36 alone. The co-administration PYY3-36 + GLP-17-36 infusion enhanced insulin secretion, but there was no additional secretion compared that with GLP-17-36 alone. Conclusion Energy intakes were significantly lower with PYY3-36+GLP-17-36 application, and PYY3-36 and GLP- 17-36 in turn. Blood glucose was reduced with PYY3-36+GLP- 1 7-36 and GLP- 17-36.
出处 《中国慢性病预防与控制》 CAS 2005年第6期292-294,共3页 Chinese Journal of Prevention and Control of Chronic Diseases
关键词 食欲抑制药 食欲 血糖 肽YY3-36 胰升糖素样肽-17-36 Peptide YY3-36 Glucagon-like peptide-17-36 Appetite Blood glucose Health Population
  • 相关文献

参考文献13

  • 1Kreyman B, Williams G, Ghatei MA, et al. Glucagon-like-peptide-1 T36: a physiological incretin in man [J]. Lancet ,1987, 5:1300-1303.
  • 2Grandt D. Two molecular forms of peptide YY(PYY) are abundant in human blood : characteri-sation of aradioimmunoassay recognising PYY1-36 and PYY3-36[J]. Regul Pept, 1994, 51:151-159.
  • 3Batterham RL, Cowley MA, Small C J, et al. Gut hormone PYY3-36 physiologically inhibits food intake[J]. Nature,2002, 418:650-654.
  • 4Cecile T, Danielle B, Matthieu L, Glucagon-like-peptide-1 and exendin-4 stimulate B-cell neogenesis in streptozotocin-treated newbore rats resulting in persistenly improved glucose homeostasis at adult age[J]. Diabetes 2002, 51:1443-1452.
  • 5Verdich C, Flint A, Gutzwiller JP, el al. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans[J]. J Clin Endocrinol Metab, 2001,86:4382-4389.
  • 6Wettergren A, Maina P, Boesby S,et al,Glucagon-like-peptide 7-36 amide and peptide YY have an additive inhibitory effect of gastric acid secretion in man[J]. Stand J Gastoreneterol, 1997, 32:552-555.
  • 7Schwartz MW, Woods SC, Porte D, et al, Central nervous system control of food intake[J].Nature, 2000, 404:661-671.
  • 8Broberger C, Landry M, Wang H, et al, Subtypes of Y1 ANG Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiome-lanocortin and neuropeptide-Y-containing neurous of the rat hypothalamic arcuate nucleas [J].Neuroendocrinlogy, 1997, 66:393-408.
  • 9Kalra SP. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight[J] Endocr,Rev, 1999, 20:68-100.
  • 10Keire DA, et al, Primary structures of PYY,[Pro^34]PYY and PYY-(3-36) confer different conformations and receptor selectivity [J].Am J Physiol Gastrointest Liver Physiol, 2000, 279:G126-131.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部